Muyuan Foods: The Pork Empire of Nanyang

I. Introduction & Episode Roadmap

Drive south from Zhengzhou into the flat, dusty loess country of southwestern Henan and you eventually reach Nanyang — a prefecture of ten million people that most foreign investors could not place on a map. Along the county roads you begin to notice the buildings. They are the wrong shape for factories and the wrong shape for apartments: long, windowless concrete slabs, six storeys high, ringed by fences, dotted with ventilation stacks and air-filtration housings, sitting in fields where wheat used to grow.

Trucks pass through disinfection tunnels at the gate. Workers enter through shower rooms and quarantine dormitories. Inside, on every floor, are pigs — tens of thousands of them, fed through pipelines, monitored by cameras, and never once touched by a farmer's hand in the way a Chinese peasant would have recognised a century ago.

This is the physical footprint of 牧原食品集团股份有限公司 Muyuan Foods, and it is the largest concentration of pork production capacity in human history. In 2025 the company sold 77.98 million hogs and slaughtered 28.66 million of them in its own plants.¹ That single-company output is roughly ten times Denmark's entire national pig slaughter and comfortably exceeds the combined finished-hog output of Germany, Spain and France. China itself produced 719.73 million hogs that year, so Muyuan alone accounted for about 10.8% of the world's largest pork market¹² — and since China represents roughly half of global pork production,¹ Muyuan produces something on the order of one in twenty pigs raised anywhere on Earth.

The company carries a market value of roughly RMB 240 billion (about $34 billion), listed in Shenzhen since 2014 as 002714.SZ and, since February 2026, in Hong Kong as 02714.HK.³⁴ Its founder, 秦英林 Qin Yinglin, and his wife 钱瑛 Qian Ying, started in 1992 with 22 pigs and a shed they built themselves.⁵ By any reasonable measure, this is one of the great wealth-creation stories of the post-Deng Chinese economy.

It is also, right now, a company losing money hand over fist.

That combination — undisputed global scale, best-in-class cost, and an income statement in the red — is what makes Muyuan worth two hours of attention rather than a paragraph.

That is the tension worth sitting with for the next two hours. In the first half of 2026, Muyuan reported revenue of RMB 59.4 billion, down 22.3% year on year, and a net loss attributable to shareholders of RMB 6.08 billion — a swing of nearly RMB 16.6 billion from the RMB 10.5 billion profit it earned in the same period a year earlier. Cash flow from operations turned negative, at minus RMB 2.22 billion.⁶ This happened despite the company hitting the lowest production cost in its history. China's hog price simply fell further and faster than even the world's cheapest producer could cut. By August 2026, live hog prices were hovering around RMB 10.4 per kilogram after a modest rebound.⁷ Muyuan's own all-in cost was about RMB 11.5.⁸

That is the whole investment question in one line. Muyuan's bull case has always been that its structural cost advantage — two to three yuan per kilogram below the national average — converts the brutal 猪周期 pig cycle from a threat into a consolidation engine: peers bleed, Muyuan doesn't, Muyuan buys share. The last eighteen months have partially falsified the strong version of that claim. Muyuan's cost lead is real and measurable, and its losses have been far smaller than the industry's. But "smallest loser" is not "always profitable," and the company's own cash flow statement now says so.

Along the way we will examine three things that make Muyuan genuinely unusual as an agricultural business. First, a founding architectural decision — to own and operate every pig itself rather than farm production out to households — that looked like financial insanity for fifteen years and then became the company's defining advantage. Second, an engineering response to African swine fever that turned biosecurity from a compliance cost into something closer to a process moat. Third, a financial structure that has drawn more sustained scepticism than almost any other large-cap in China: a mountain of self-built fixed assets, a construction affiliate owned by the founder's family, a biological-asset balance that its own auditor flags as a key judgement, and a debt load that crossed RMB 120 billion at its peak.

The route runs chronologically. We start with two agricultural-college graduates and a shed in 1992, then the architectural fork in the road that separated Muyuan from every other Chinese pig company. We spend real time on 2018 to 2020, when a virus with no vaccine destroyed roughly two-fifths of China's pig herd and turned Muyuan's most criticised decision into its most valuable one. Then the reckoning: the price crash, the exchange inquiries, the regulatory interview, the debt. Then the machine itself — how a company actually gets its cost of production two-and-a-half yuan below the national average, in terms that do not require an animal-science degree. And finally the present: a new management team, a Hong Kong listing, a Vietnamese joint venture, and an industry the Chinese state is actively trying to shrink.

We will also meet the people. Qin Yinglin, the agricultural-college graduate who quit a state job to raise pigs and became Henan's richest man. And, as of June 2026, the successors: a chairman who is his wife's cousin, a chief financial officer born in the 1990s who now also holds the president's title, and a thirty-one-year-old son named — with no subtlety whatsoever — 秦牧原 Qin Muyuan.⁹

Let's start where all of this started: with 22 pigs.

↑ Back to Top

II. Founding Context & The 22-Pig Genesis (1992–2000s)

In 1989, Qin Yinglin graduated from 河南农业大学 Henan Agricultural University with a degree in animal husbandry and was assigned to a state work unit — the Nanyang regional food company.⁵ Born in 1965 in Neixiang County, a poor mountain area in Henan, he had achieved what millions of his generation sought: a stable salary, a state work unit, and an orderly career track.

Three years later, he walked away. In 1992, Qin and his wife Qian Ying — a veterinary graduate of the Zhengzhou Animal Husbandry School — resigned their positions to raise pigs in the countryside.⁵ In June 1993, they bought 22 head.⁵

The timing was notable. In 1992, 邓小平 Deng Xiaoping's 南方谈话 Southern Tour signaled that private enterprise and market reform were permanent policies. As China urbanized and household incomes rose throughout the 1990s, consumer demand shifted. When Chinese households become wealthier, their consumption of pork rises rapidly — a protein central to the national diet and to state food-security priorities.

Pork has never been a simple commodity in China; it functions as a political price index. To this day, the Ministry of Agriculture and Rural Affairs publishes national sow-herd targets and intervenes when inventory strays outside a designated "green zone."¹

While rising demand was clear, the supply structure was highly fragmented. In the early 1990s, Chinese pork came overwhelmingly from 散户 (sanhu) — backyard smallholders keeping a handful of pigs on kitchen scraps and crop residues. This low-capital model possessed severe operational weaknesses. Feed efficiency was low; the 料肉比 feed-to-meat ratio — the kilograms of feed required to produce one kilogram of live weight — was far worse in backyard pens than in modern facilities. Because feed represents the single largest cost in hog production, this created a persistent cost disadvantage. Disease prevention was minimal, and because millions of independent smallholders expanded herds during price rallies and liquidated during slumps, supply responses were wildly procyclical, driving China's volatile three-to-four-year 猪周期 pig cycle.

This cycle is driven by biological lag. A sow's gestation takes about 114 days, and a piglet requires roughly six months to reach market weight. Consequently, a decision to expand breeding herds today yields market supply ten months later. When prices rise, uncoordinated producers expand simultaneously, creating a supply glut ten months later that depresses prices. Conversely, price crashes trigger widespread herd liquidations — including breeding sows — leading to acute supply shortages ten months later. This built-in biological delay creates a structural flywheel of boom-and-bust cycles, causing Chinese hog prices to swing by factors of three or four over multi-year periods.

Qin's core strategic insight was to approach hog farming as an industrial process-control challenge rather than traditional agriculture. Key profitability metrics — feed efficiency, weight-gain velocity, litter size, and mortality rates — can be systematically optimized, provided the producer controls the entire environment. This philosophy required formulating proprietary feed blends, breeding proprietary genetics rather than purchasing market piglets, and engineering biosecure facilities to exclude pathogens.

Muyuan scaled steadily over the following two decades. Within two years of launching, the herd grew from 22 head to 2,000. By 1997, annual sales reached 10,000 finished hogs. In 2005, the company imported 470 breeding pigs from Canada to establish a domestic nucleus herd, formalizing genetics as an in-house core competency.⁵ By 2013, the year prior to its Shenzhen listing, annual volume exceeded one million head.⁵

Chinese business media often frames this origin story as a romantic folk tale of a farm couple building an empire from 22 pigs. A more analytical perspective reveals a strategy grounded in technical expertise. Qin and Qian were university-trained animal scientists who recognized that long-term cost leadership in swine production depended on nutrition optimization and biosecurity. Subsequent innovations — including low-soybean-meal feed formulas, multi-storey air-filtered barns, and closed-loop breeding programs — stemmed directly from this technical orientation.

However, executing this self-operated model demanded capital at a scale that traditional agricultural lenders were ill-equipped to provide. Managing that capital intensity would define — and periodically jeopardize — the company's expansion for the next two decades.

↑ Back to Top

III. The Architectural Bet: Direct Self-Raising vs. The Contract Model (2000s–2014)

By the mid-2000s, China's emerging commercial hog industry had reached a strategic fork, and nearly every major competitor except Muyuan chose the same path.

The dominant approach was 公司+农户 ("company plus farmer"). Pioneered by 温氏食品集团股份有限公司 Wens Foodstuff Group in Guangdong and later adopted at scale by 新希望六和股份有限公司 New Hope Liuhe, the model operated like a franchise. The central company managed the capital-intensive and technically demanding stages of the chain—breeding genetics, feed milling, veterinary support, and marketing—and delivered weaned piglets and feed to thousands of contracted rural households. The farmers supplied the land, pens, and labor to fatten the animals under corporate protocols, earning a fee per finished pig.

The model offered clear financial advantages. The contract farmers' facilities never appeared on the corporate balance sheet. Expansion was limited only by how quickly a company could recruit households, rather than how fast it could raise equity and debt. Capital turnover and return on invested capital remained high, allowing companies to scale rapidly in favorable market conditions with a fraction of the capital required for a fully owned system. In an industry where live hog prices frequently swung by factors of three or four, shifting fixed costs off corporate balance sheets onto growers served as a primary risk-mitigation strategy.

Muyuan chose the opposite path. Under 一体化自养 (integrated self-raising), the company acquired land rights, designed and constructed its own facilities, milled its own feed, bred its own sows, employed every stockperson directly, and maintained ownership of every animal from conception to slaughter. The individual contract farmer was removed entirely from the production chain.

For nearly fifteen years, this strategy appeared financially disadvantageous to industry observers. The approach combined a low-margin, highly cyclical commodity business with the heavy balance sheet of an industrial manufacturer. Adding capacity required substantial upfront capital for land rights, concrete, steel, and automated ventilation systems that could not be repurposed for other uses. Depreciation incurred a heavy fixed cost regardless of prevailing pork prices, dampening asset turnover and making debt financing necessary—a combination that historically posed severe solvency risks during prolonged cyclical downturns.

Muyuan's financial performance during this period highlighted that operational leverage. In the cyclical trough of 2014, the company generated RMB 80 million in net profit on RMB 2.6 billion in revenue—a net margin of roughly 3 percent. In 2015, as market conditions recovered, net profit surged to RMB 596 million on revenue of RMB 3.0 billion.

However, total operational ownership yielded distinct structural advantages. Direct control allowed Muyuan to standardize operations across its entire network: a uniform genetic line tailored to a single nutrition program, centralized feed formulations pushed simultaneously to every barn, and proprietary facility designs refined iteratively and deployed systematically across all sites. Direct employment contracts also made strict biosecurity protocols a mandatory job requirement rather than a contractual guideline subject to individual grower compliance.

This control structure also provided a significant data advantage. While contract networks relied on fragmented and self-reported recordkeeping across thousands of independent farms, a directly operated model produced a continuous, standardized dataset across every facility. Because every barn operated under identical protocols, operational deviations served as immediate diagnostic signals. This standardized foundation later enabled the integration of automated feeding systems and IoT sensor monitoring across the estate.

Institutional capital backed the model prior to its public listing. In October 2010, the International Finance Corporation—the World Bank Group's private-sector arm—made a $9.59 million equity investment in the company to support its expansion from roughly 500,000 to one million hogs annually through new breeding and commercial farms in Henan.¹⁰

Muyuan completed its initial public offering on January 28, 2014, listing shares on the Shenzhen Stock Exchange's SME board at an offer price of RMB 24.07, representing a price-to-earnings multiple of 18.8 times.¹¹ The offering raised approximately RMB 722 million in net proceeds from 60.5 million new shares. Beyond the immediate capital, the listing established access to public equity, bond, and convertible debt markets, providing the financial flexibility to fund further large-scale facility construction.

Muyuan's decision to pursue self-raising was not based on anticipating future disease outbreaks, but on the conviction that direct process control was the primary mechanism for achieving long-term unit-cost leadership in a commodity market. While the strategy imposed significant balance-sheet weight for over a decade, its operational implications would become decisive when African swine fever altered the industry landscape.

↑ Back to Top

IV. The African Swine Fever Catalyst & The "Pig Skyscraper" Era (2018–2020)

The first confirmed cases of African swine fever appeared in northeastern China in August 2018.¹² The virus posed no threat to humans, which initially muted public attention outside the agricultural sector until its economic toll became impossible to ignore. African swine fever kills domestic pigs at rates approaching 100%, survives for months in frozen meat and contaminated feed, spreads easily on vehicle tires and boots, and has no approved vaccine.

Within a year, the virus had spread to every province in China.¹² By October 2019, China's swine inventory had fallen more than 40% year on year, driven by animal mortality and widespread preemptive liquidations by farmers.¹² Fourth-quarter 2019 pork output dropped by more than 30%. Annual production for 2020 was projected to fall to 36 million tonnes from 54 million in 2018—wiping out a third of the world's largest meat supply.¹²

Predictably, prices spiked. Chinese pork prices more than doubled during the second half of 2019; a 97% year-on-year increase in December 2019 contributed more than half of the country's 4.3% overall consumer price inflation for that month.¹² China's pork imports rose to a record 3.7 million tonnes in 2020, up from 1.6 million in 2018.¹² What began as an animal health crisis had rapidly escalated into a national macroeconomic shock.

The outbreak severely tested the industry's two competing business models. Under contract farming, livestock was distributed across thousands of independently owned smallholder pens serviced by shared transport, with variable biosecurity discipline and limited capital for air filtration or disinfection infrastructure. Enforcing uniform biosecurity across such a fragmented network proved nearly impossible. Protocols could be written, but monitoring compliance and installing specialized equipment across thousands of independent locations was impractical. For a pathogen transmitted via footwear and transport vehicles, a decentralized network presented inherent structural vulnerabilities.

In contrast, effective biosecurity functions much like a hospital operating theater: rather than trying to sterilize the surrounding environment, operators enclose a controlled space and strictly regulate every entry point. Air filtration serves as the first line of defense; by maintaining positive internal air pressure, air flows outward through structural gaps, ensuring pigs breathe only filtered air. Transport vehicles represent a second vector, requiring multi-stage washing, chemical disinfection, and thermal baking before entering facilities. Human traffic is a third vector, managed through mandatory shower-in procedures, specialized clothing, and quarantine protocols. Feed delivery forms the fourth, utilizing sealed pipeline systems rather than open trucks unloading into pens. While each protocol is standard practice in advanced animal husbandry, executing them continuously across every facility without exception requires comprehensive operational control.

Muyuan's fully integrated model provided that baseline control. Its facilities were constructed as enclosed, environmentally controlled units featuring scrubbed, pressure-managed ventilation systems. Delivery vehicles passed through centralized disinfection stations, staff stayed in on-site dormitories subject to quarantine protocols, and feed moved through sealed pipelines. While individual components of this design were common among European and North American commercial integrators, Muyuan was unique in owning sufficient infrastructure to deploy them across its entire enterprise simultaneously.

This design philosophy culminated in 楼房养猪—high-rise pig farming. To minimize land exposure and reduce defensive perimeters against airborne and localized pathogens, producers stacked housing facilities vertically. Muyuan built multi-storey complexes—typically six storeys high, with some structures reaching up to thirteen—featuring independent ventilation systems per floor, internal elevator and pipeline feed transport, and biosecurity zoning that isolated each floor as a separate epidemiological unit.¹³ The model delivered significant spatial efficiency, with Muyuan claiming its later-generation high-rise designs achieved more than six times the land-use efficiency of traditional horizontal farms.¹⁴ In China, where arable land is tightly protected and environmental permitting for livestock is strictly regulated, vertical spatial efficiency offered compelling operational benefits alongside disease containment.

These high-rise facilities captured widespread international media attention, with outlets like the Financial Times highlighting how China's vertical farms were transforming global pork production.¹⁵ Rival operator Hubei Zhongxin Kaiwei took the concept even further, constructing twin 26-storey towers in Ezhou designed to produce 1.2 million pigs annually across 390,000 square meters of floor space with over 800 employees.¹⁶ However, the iconic single-building skyscrapers were not Muyuan's primary innovation. Muyuan's main contribution was operational scale: constructing massive integrated multi-building complexes—such as its flagship site in Neixiang County—that combined feed milling, multi-storey breeding, and slaughter operations within a single biosecure perimeter.

The financial returns generated during the African swine fever cycle were unprecedented, if transitory. Muyuan generated a net profit of approximately RMB 520 million in 2018, which rose to RMB 6.1 billion in 2019. At the market peak in 2020, net profit reached RMB 27.5 billion—a fifty-fold increase in two years.⁴ The surge briefly made Qin Yinglin one of the wealthiest individuals in Asia.

Physical output expanded rapidly alongside earnings, leaving a permanent operational footprint even after pork prices normalized. Muyuan sold 18.11 million hogs in 2020, 40.26 million in 2021, and 61.2 million in 2022.¹⁷ The company more than tripled its sales volume over the two years following the outbreak, expanding its market footprint while the broader domestic industry was still repopulating herds. The lasting legacy of the crisis for Muyuan was not its temporary profit surge, but the substantial expansion of its installed production capacity.

However, this aggressive expansion introduced significant balance-sheet risk. Rather than conserving the cash windfall, Muyuan reinvested heavily into new capital expenditure. Net property, plant, and equipment grew from RMB 17.2 billion at the end of 2018 to RMB 80.6 billion at year-end 2020, reaching RMB 120.5 billion by late 2022.⁴ This sevenfold expansion of physical assets in four years was financed largely through debt and equity capital raised at the subsidiary level. The company deployed unprecedented capital at the height of an extraordinary price cycle.

In commodity markets, historic price peaks inevitably incentivize new supply, eventually depressing market prices. Capacity added at cyclical tops often carries the highest financial risk. While Muyuan management maintained that capital was deployed to secure long-term, low-cost capacity rather than chase short-term market prices, the subsequent market downturn would put that strategy to a rigorous test.

↑ Back to Top

V. The Pig Cycle Crash & The Skeptical Investor Stress Test (2021–2023)

The reckoning arrived on schedule. By 2021 the national herd had been rebuilt — over-rebuilt — as every listed producer and every regional government-backed project raced to capture ASF-era margins. Prices collapsed below the cash cost of most producers and stayed there.

The industry's casualty list was gruesome. 江西正邦科技股份有限公司 Zhengbang Technology, once among China's largest hog producers, lost RMB 18.82 billion in 2021 and a further RMB 13.39 billion in 2022; in October 2022 its capital chain broke, creditors pushed it into bankruptcy restructuring, and by the end of 2023 control had passed to a consortium led by the Shuangbaotai agricultural group.¹⁸ New Hope and Wens both posted enormous losses. In the third quarter of 2023 alone, China's three largest listed hog producers reported combined losses of RMB 10.23 billion.¹⁹ By the end of that year the Wall Street Journal was reporting Chinese hog prices falling as supply surged, weighing directly on Muyuan and Wens.²⁰ Muyuan itself finally broke: a net loss of RMB 4.26 billion in 2023, its first annual loss as a public company.¹

There is a useful detail buried in that loss. Muyuan lost money in 2023 while running an operation several times the size of its 2020 self, at a materially lower cost per kilogram than it had achieved during the boom. The company had become far better at its craft and still could not clear its costs. That is the nature of a commodity: excellence is relative, and relative excellence does not pay the interest bill.

A fourth line of scepticism emerged in October 2023 and is worth recording because of how management handled it. Screenshots of an internal restructuring proposal — the 共创制, or "co-creation system," under which farm units would share in the profits and losses they generated — leaked online, and the stock fell 7.63% in a single session on fears that Muyuan was quietly converting itself into a contract-farming business. Board secretary Qin Jun responded that it was an internal incentive experiment that "has not altered the company's vertically integrated model," and the company's chief operating officer said roughly 1,000 units were participating, about 1% of the total, with 70% showing positive results and participant pay up 20–30%.¹⁹ The episode is minor in financial terms but revealing in two ways: the market's instinctive fear was that Muyuan would abandon the very architecture that defines it, and management's answer was specific and quantified rather than defensive — a better response than the 2021 disclosure episode.

But the more interesting stress test in this period was not operational. It was forensic. Between 2021 and 2024, Muyuan became the most systematically doubted large-cap in Chinese agriculture, and the questions raised then remain the right questions to ask today.

The construction affiliate. The central concern was 河南牧原建筑工程有限公司 Henan Muyuan Construction, a company wholly owned by Muyuan Industrial Group — which is itself owned entirely by Qin Yinglin and Qian Ying.¹ Muyuan the listed company builds enormous quantities of concrete every year, and a very large share of that construction was awarded to a builder controlled by the controlling shareholders. In 2021, related-party construction services and equipment purchases with this affiliate ran to roughly RMB 14.9 billion, with a further RMB 7.1 billion in associated payables.²¹

The bear's mechanism is straightforward and does not require anyone to be a criminal: if a listed company overpays a founder-owned builder for capital works, the excess disappears into capitalised fixed assets rather than showing up as an expense. Profits look fine. Cash quietly leaves.

And because the asset base is enormous and idiosyncratic, no outside analyst can benchmark whether a given price per square metre of pig barn is fair. There is no comparable transaction, because nobody else builds these buildings at this scale.

Muyuan's answer — repeated across investor meetings and exchange responses — was the inverse: that building in-house removed a third-party developer's margin and was a source of cost advantage, not a leak. That claim is not absurd. It is also, structurally, unfalsifiable from outside. What can be observed is the trajectory. Related-party transactions with the construction affiliate fell to about RMB 3.49 billion by 2023,²² and in fiscal 2025 transactions with Henan Muyuan Construction and its subsidiaries totalled RMB 4.0 billion, disclosed as 35.83% of that transaction category and running right up against a board-approved cap of RMB 4.0 billion.²³ So the practice has shrunk dramatically in absolute terms and is now capped and disclosed — but it has not ended, and more than a third of the relevant procurement still goes to the founder's family company. An activist would note that a cap the company transacts to within a rounding error is a cap that binds, and would ask what happens at the next renewal.

Asset intensity and impairment. The second line of attack concerned what all that concrete was worth. In 2021, while Wens lost RMB 13.6 billion and New Hope lost RMB 9.5 billion, Muyuan reported nearly RMB 7 billion of profit — and took essentially no impairment on either its fixed assets or its consumable biological assets.²¹ The Shenzhen Stock Exchange asked why. Muyuan's response was that asset retirements reflected deliberate upgrades for efficiency and biosecurity rather than obsolescence, and that its accounting followed the standards.²¹ The pattern persisted: no meaningful biological-asset impairment until a RMB 159 million charge late in 2023, against a fixed-asset base worth tens of billions.²¹

This is not evidence of wrongdoing. It is evidence that a very large amount of Muyuan's reported earnings depends on management judgements that are hard to audit from outside — and Muyuan's own auditor agrees. In the fiscal 2025 accounts, KPMG Huazhen identified biological-asset impairment as a key audit matter, noting that consumable and productive biological assets carried a combined book value of RMB 36.59 billion, equal to 21.30% of total assets, and that assessing their recoverable value requires significant management judgement.²³ A fifth of the balance sheet is living animals whose value depends on a forecast of future hog prices. Investors should hold that fact in view permanently, not just in downturns.

Leverage. The third concern was the simplest. Total liabilities peaked at RMB 121.4 billion at the end of 2023 — roughly $17 billion — against equity attributable to shareholders of RMB 62.8 billion, for a debt-to-assets ratio near 60%.¹ By the third quarter of 2023 the ratio stood at 59.68%, with short-term borrowings of RMB 45.3 billion against cash of RMB 13.3 billion.¹⁹ Muyuan was funding very long-lived assets with very short-dated money, in the middle of a loss-making period, in an industry whose lenders can turn hostile fast.

The exchange returned to this in May 2024, asking Muyuan to explain its repayment plan for debt maturing within a year — short-term borrowings had risen 60.91% to RMB 46.9 billion, and current liabilities exceeded current assets by RMB 31.1 billion — and whether there was genuine uncertainty about timely repayment. The same letter probed why soybean meal had fallen to 5.7% of feed against an industry average of 14.5%, and demanded justification of RMB 3.49 billion in related-party dealings.²² Management's replies emphasised that new short-term borrowing came from state-owned and commercial banks at costs under 4%, and that the low soybean inclusion reflected amino-acid-balanced formulations rather than under-feeding.²²

A related pattern is worth a brief aside, because Chinese analysts gave it a name: 存贷双高, "high cash and high debt simultaneously." A company that borrows heavily on short tenors while also holding large balances and deploying billions into financial investments invites the question of why it is doing both. Muyuan's 2025 cash flow statement shows RMB 12.34 billion paid out for investments during the year, against RMB 21.07 billion in 2024, while the company simultaneously carried more than RMB 50 billion of short-term borrowings.²³ There are perfectly ordinary explanations — treasury management across 320 subsidiaries, bank relationship requirements, working-capital timing. There is also a less comfortable one, which is that gross balances can obscure how tight the net liquidity position actually is. It is not an accusation; it is a reason to read the cash flow statement rather than the cash balance.

The governance blemish. One episode deserves naming plainly because it goes to management credibility rather than accounting. In March 2021, with media questioning the company's financials and a Shenzhen Stock Exchange inquiry already outstanding, Muyuan submitted materials to the China Securities Regulatory Commission for a convertible bond issue stating that there were no major matters affecting the issuance or investors' judgement. Qin Yinglin signed those materials as chairman and legal representative. On April 30, 2021, the CSRC determined this violated the Administrative Measures for Securities Issuance by Listed Companies and ordered him to appear in Beijing for a regulatory interview on May 11.²⁴ The measure sits at the mild end of the CSRC's toolkit — no fine, no ban, no formal case. But the substance is that the founder-chairman certified to the regulator that nothing material was pending at the precise moment something material was pending, in service of raising money. That is a real data point about how this management team behaves when capital is at stake.

There were course corrections. Muyuan opened farm sites to institutional investors and analysts. Related-party dealings shrank and moved under formal board-approved caps. And after 2023 the capital-spending programme was throttled hard: capital expenditure fell from RMB 12.38 billion in 2024 to RMB 9.53 billion in 2025,²³ with 2026 guided below RMB 10 billion of which RMB 6–7 billion is routine maintenance.²⁵ Total liabilities fell by RMB 17.1 billion during 2025 and the debt ratio dropped 4.53 percentage points to 54.15%.¹

One second-layer signal is worth watching alongside the equity story: the credit view. China Chengxin has maintained an AA+ issuer rating with a stable outlook, most recently reaffirmed in May 2025, and the convertible bond carries the same rating.¹ Domestic ratings scales are compressed and AA+ is a common level for large listed corporates, so this is not a strong endorsement — but a downgrade would be a genuinely material event for a company that rolls tens of billions of yuan of short-term bank debt. For an equity holder, the ratings agency and the bank syndicate are effectively the senior claimants whose patience determines whether the cycle is survivable. Their behaviour is worth tracking more closely than the share price.

The honest read is that the sceptics were directionally right about the risk and wrong about the outcome — so far. Muyuan did over-build into a peak, did fund it too short, and did rely on judgement-heavy accounting and family-affiliated construction while doing it. It also did not break, deleveraged materially once prices recovered, and has kept its disclosure within the rules. What has not been proven is the thing bulls most want to believe: that the fixed-asset base was worth what was paid for it. The only test that matters is whether it generates enough cash across a full cycle. Which brings us to the machine itself.

↑ Back to Top

VI. Unit Economics, Cost Leadership, & Segment Mechanics

Strip away the buildings and the drama and Muyuan is a spread business. It buys corn, wheat, soybean meal and amino acids; it converts them into live weight; it sells that weight. Everything else is detail.

The revenue split reflects that. In fiscal 2025 the farming segment generated RMB 140.2 billion of revenue at a gross margin of 17.29%, down 3.64 percentage points as hog prices fell. The slaughtering and meat-processing segment generated RMB 45.2 billion at a gross margin of 2.67%, up 1.65 points.²³ Those two figures sum to more than the company's consolidated revenue of RMB 144.1 billion, and the gap is the point: most of the hogs the slaughterhouses process come from Muyuan's own farms, and the internal transfer is eliminated on consolidation.

Slaughtering is not really a separate profit pool; it is a distribution channel bolted onto the farm.

Feed milling, the third pillar, has no external revenue at all. It is a cost centre that exists to feed the company's own animals, which is precisely why it matters — it is where the nutrition science becomes a cost advantage rather than a research paper.

The slaughtering economics deserve a moment because they are widely misread. Muyuan slaughtered about 36.75% of its own hogs in 2025, meaning nearly two-thirds still went to third-party processors and traders.⁸ Raising that ratio is the stated ambition, and each point of increase captures a margin that currently accrues to someone else. But the segment's gross margin of 2.67%²³ tells you how thin that captured margin is. Slaughtering is not a profit engine; it is an insurance policy against being a price-taker in a spot market, plus an information channel back to the breeding programme. Judged as insurance and information it looks like sensible integration. Judged as a growth business it would be a stretch, and investors should be careful which claim they are underwriting.

The golden metric. The number that determines everything is 全成本 — complete or all-in cost per kilogram of live weight, covering feed, veterinary inputs, labour, depreciation, energy and overhead. The industry runs on it, and the gap between a company's all-in cost and the national spot hog price is, essentially, its profit.

Muyuan's trajectory here has been relentless. All-in cost was about RMB 14 per kilogram through 2024, falling to roughly RMB 13 by that year's close.¹⁷ For full-year 2025 it averaged about RMB 12 per kilogram, roughly RMB 2 better than the prior year.¹ By March 2026 it had reached RMB 11.6, and by mid-2026 about RMB 11.5, with the best-performing farm lines running below RMB 11.²⁶⁸ Management has set a year-end 2026 target below RMB 11.5 and has spoken at shareholder meetings about an eventual ambition below RMB 10, while acknowledging that some sites still sit at RMB 12–13.²⁵ On the first-quarter 2026 call, chief financial officer 高同 Gao Tong noted that non-cash charges such as depreciation account for roughly 13.2% of that figure, implying a cash cost near RMB 10.06 per kilogram.²⁷

The peer comparison gives that number meaning. The national average all-in cost in 2025 was around RMB 14.1 per kilogram, putting Muyuan roughly RMB 2.5 below the industry.²⁶ New Hope reported RMB 12.2 per kilogram for finished hogs by December 2025.²⁸ Zhengbang, post-restructuring, was still running near RMB 15 with capacity utilisation below 50%.¹⁸ Wens does not disclose an identical metric but has guided to comparable ranges.

What does a two-yuan-per-kilogram gap actually buy? At roughly 120 kilograms of live weight per finished hog and roughly 78 million hogs, each yuan of cost advantage is worth on the order of RMB 9 billion of pre-tax profit relative to an average-cost producer. That is the engine. It is also why Muyuan can survive prices that liquidate everyone else — and why, when prices fall below even its cost, the loss per animal is small enough to absorb. In the first half of 2026, with hog prices averaging about RMB 10.4 per kilogram and touching RMB 9.69 in June, Muyuan's loss worked out to roughly RMB 66 per pig; the industry's self-breeding average loss exceeded RMB 300.²⁶

Where the advantage comes from. Three mechanisms, and they are worth explaining plainly.

The first is feed formulation. A pig does not need "protein"; it needs specific amino acids. Conventional feed delivers them by loading in soybean meal, which supplies the amino acids the animal needs plus a great deal it does not, all at soybean prices set in Chicago and São Paulo. Muyuan's approach — refined since the early 2000s — strips out surplus protein and adds industrially fermented amino acids directly, hitting the same nutritional target with far less soy.

The result is the number that so puzzled the exchange: soybean meal at 5.7% of feed against an industry average of 14.5%.²² The effect is twofold: lower feed cost per kilogram of gain, and dramatically reduced exposure to the single most geopolitically volatile input in the whole system.

The second is reproductive efficiency, measured as PSY — pigs weaned per sow per year. A sow is a fixed cost: she eats, she occupies space, she requires staff. Every additional piglet she raises spreads that cost thinner. Muyuan's PSY improved from 26.7 to 28.3 over roughly eighteen months into mid-2026, a gain that recovered close to 40% of the output the company gave up when it deliberately shrank its sow herd from 3.62 million head in early 2025 to 3.11 million by June 2026 in response to national capacity-control directives.²⁶

That is an important and under-appreciated dynamic: efficiency gains partially defeat the government's attempts to cut supply, which is one reason this downturn has lasted so long.

The third is automation and labour productivity. Muyuan employed 127,550 people at the end of 2025 across 320 subsidiaries in 25 provinces, and spent RMB 1.65 billion on research and development, or 1.14% of revenue.²³ Much of that R&D goes into equipment and software: automated feeding lines, environmental control, sensor-based health monitoring.

The company's stated direction, articulated by Gao Tong at the 2026 annual meeting, is to convert accumulated production data into AI-driven management systems.²⁵ Investors should note the framing carefully. Muyuan's R&D intensity is modest by technology-company standards and actually declined 5.67% in 2025.²³

This is an engineering-and-operations company that uses software, not a software company. The productivity claims — one technician overseeing thousands of finishing pigs — are plausible and consistent with the cost data, but they are management-reported rather than independently verified.

Myth versus reality. Three consensus narratives about this company deserve fact-checking against the record.

Myth: Muyuan is a technology company that happens to raise pigs. The reality is a heavy industrial operator that applies technology well. Research and development ran to 1.14% of revenue in 2025 and fell in absolute terms.²³ Depreciation and amortisation, by contrast, ran above RMB 15 billion. The economics are those of a plant, not a platform, and the valuation framework should follow.

Myth: the "pig skyscraper" is Muyuan's signature innovation. The reality is that the tallest and most photographed towers belong to a competitor,¹⁶ and Muyuan's multi-storey buildings are typically six storeys.¹³ The company's genuine differentiator is less telegenic: integrating feed milling, breeding, finishing and slaughter on single sites under one biosecurity perimeter, then replicating that template across 25 provinces.

Myth: Muyuan's model makes it immune to the pig cycle. Management has never actually claimed immunity — on the first-quarter 2026 call the framing was that the company had prepared to survive an extended downturn, not to avoid it.²⁷ The market narrative overshot the company's own language, and the first half of 2026 settled the question with a loss and negative operating cash flow.⁶

The calibrated conclusion: Muyuan's cost leadership is the most thoroughly evidenced claim in the entire investment case. It shows up in the audited accounts, in relative profitability against every listed peer through both up and down cycles, and in an input-mix statistic a regulator forced the company to defend in detail. What the last two years have narrowed is the consequence of that leadership. Being cheapest guarantees relative outperformance. It does not guarantee absolute profit, and the first half of 2026 proved it.

↑ Back to Top

VII. Competitive Landscape & Industry Structure

Picture China's hog industry in 2010 as a vast, shallow lake — hundreds of millions of animals spread across tens of millions of household producers, with no single operator meaningful enough to move a price. Now picture it in 2026: the Ministry of Agriculture estimates the scaled-farming share reached roughly 73% in 2025, and the top handful of listed producers between them account for something like a fifth of national output.¹ The lake is draining into a few very deep pools.

The field. Muyuan sits alone at the top with 77.98 million hogs and 10.8% national share.¹² Wens is second, having sold 40.48 million pigs in 2025 for a 5.6% share, alongside 1.30 billion birds of poultry — a genuinely diversified protein business that earned RMB 5.27 billion in 2025, down 43.25%, on revenue of RMB 103.8 billion.²⁹ New Hope is third at 17.55 million hogs, but its centre of gravity is feed: 29.74 million tonnes sold in 2025, up 15%, including 6.38 million tonnes overseas. New Hope's hog business dragged the group to a net loss of RMB 1.78 billion in 2025 on revenue of RMB 106.9 billion, after fourth-quarter price collapse, biological-asset provisions and fixed-asset disposals.²⁸

Behind the top three sits a long tail of regional operators, restructured former champions and state-linked projects, most of them running costs a yuan or two above the leaders. That tail is where consolidation happens. It is also, perversely, why consolidation is slow: much of that capacity was financed by local banks and local governments with reasons to keep it running.

The comparison is instructive precisely because these three are not running the same business. Wens' contract model gives it lower capital intensity and a poultry hedge, at the cost of a structurally higher hog production cost and less control. New Hope's feed division earns a steady processing margin regardless of hog prices, but its farming arm has been a persistent value destroyer. Muyuan is the pure-play: maximum operating leverage to the hog price, maximum control of cost, minimum diversification. In 2025 that meant Muyuan earned RMB 15.5 billion while New Hope lost money — a stark demonstration of the cost gap. In a longer trough, it also means Muyuan has nowhere to hide.

There is also a competitive dimension that does not show up in volume tables: newness. A substantial share of Muyuan's barns were built between 2019 and 2022, which means they embody the most recent generation of design and are only partway through their depreciation schedules. That cuts both ways. New assets are more efficient, which flatters the operating cost line. New assets also carry the heaviest depreciation charge, which is why Muyuan's cash cost sits roughly RMB 1.5 below its all-in cost.²⁷ A competitor running older, fully depreciated barns has worse operating efficiency but a lower accounting cost floor — one reason high-cost capacity in this industry is so slow to exit.

Downstream sits a different kind of power. 万洲国际有限公司 WH Group and its mainland subsidiary 双汇发展 Shuanghui Development dominate branded and processed pork, and they are simultaneously among the largest buyers of live hogs in China and, increasingly, competitors to Muyuan's own slaughter operations.

That dual role is the single most important structural fact about Muyuan's downstream push: every kilogram Muyuan slaughters itself is a kilogram it no longer sells to a processor, and slaughter capacity in China is already oversupplied. The national designated-slaughterhouse volume rose from 191.16 million head in 2019 to 411.37 million in 2025, lifting the regulated share from 35.13% to 57.16%,¹ which is consolidation — but consolidation into an industry the annual report itself describes as running below full capacity utilisation.

The policy layer. China's pork market is managed, not free. The Ministry of Agriculture sets a national sow-herd target and has repeatedly adjusted it: 41 million head in the 2021 framework, cut to 39 million in March 2024, and cut again to 37.5 million by May 2026.¹²⁶ Through 2025 and 2026 the ministry convened repeated meetings instructing producers to cull low-productivity sows, curb secondary fattening, control slaughter weights and strictly limit new capacity.¹

By the end of the second quarter of 2026 the national sow herd had fallen to 37.8 million, down 6.5% year on year and equal to 100.8% of the target — back inside the "green zone."⁷

Layered on top is a political frame. The consolidation of Chinese agriculture into large corporate operators sits somewhat awkwardly alongside 共同富裕 common prosperity, the policy emphasis on narrowing income gaps and supporting rural livelihoods. Beijing wants food security, environmental compliance and traceable food safety, all of which favour scale. It also does not want tens of millions of rural households displaced by industrial farms. Muyuan's response has been to position itself as an enabler rather than a displacer — supplying piglets and disease-control services to smaller farms, hosting the World Pork Expo, and framing its technical exchanges with 正大集团 Charoen Pokphand, Wens, New Hope and others as industry uplift.¹ Read cynically, that is licence maintenance. Read practically, licence maintenance is a real and recurring cost of operating at this scale in this country, and a company that neglects it faces permitting and policy risk that never appears in a financial model.

For a scaled producer this policy regime is double-edged. It caps the upside — Muyuan cannot simply out-build the cycle, and in the first half of 2026 it suspended construction on facilities representing 1.2 million head of capacity and stopped selling to secondary fatteners in line with official guidance.²⁶ But it also raises barriers, since environmental permitting and land-use approval for new livestock sites now favour operators with capital, compliance systems and political relationships. Muyuan's own environmental technology — its ammonia-reduction and deodorising system was promoted by the Ministry of Ecology and Environment and selected as a 2025 recommended agricultural technology — is as much a regulatory asset as an environmental one.¹

How it wins. The mechanism is unglamorous: be the last producer still generating cash at any given price, let higher-cost capacity exit, and pick up the share. It has demonstrably worked once — Muyuan's national share roughly doubled from about 6% in 2021 to 10.8% in 2025 across exactly the period that destroyed Zhengbang and mauled New Hope.²

How it loses. Three mechanisms, in rough order of probability. First, a price trough that outlasts the balance sheet's patience — not because Muyuan's cost is beaten, but because sustained prices near RMB 10 mean years of cash burn while RMB 15 billion of annual depreciation grinds on regardless.

Second, a biosecurity failure inside the high-density architecture. Concentrating hundreds of thousands of animals behind engineered defences is a trade: dramatically lower probability of infection, dramatically higher consequence if it happens. There is no vaccine for ASF, and a novel or filtration-defeating pathogen would hit Muyuan's model harder than a dispersed one. Third, credit. Muyuan funds long assets with short money by choice, on the grounds that short bank credit is cheap. That works until it doesn't.

The competitive question is therefore not whether Muyuan is the best operator — the evidence says it is. It is whether being the best operator in a policy-managed, capital-intensive, structurally over-supplied commodity is a business worth owning at any given price. Management's answer is that it becomes one once the industry finishes consolidating. That is the strategy we turn to now.

↑ Back to Top

VIII. Strategy, Capital Allocation, & Management Transition

On June 1, 2026, Muyuan announced that Qin Yinglin had resigned as chairman and president, citing retirement age. He became lifetime honorary chairman and dean of the company's pig-breeding research institute — a move that keeps him inside the technical core of the business while removing him from executive command.⁹

The successors say a good deal about how this company thinks about itself. 曹治年 Cao Zhinian, born in 1977, became chairman. He joined Muyuan in 1998, when the company was still selling perhaps twenty thousand pigs a year, and worked up through finance supervisor, finance manager, chief financial officer and deputy general manager. He is also Qian Ying's cousin.⁹ Gao Tong, who joined in 2017 from an overseas business school and rose through finance to CFO, added the president's title while retaining the finance function.⁹ And Qin Muyuan, born in 1995 and the founder's son, was nominated to the board; since 2019 he has worked on meat processing and downstream consumer markets rather than the core farming business.⁹

Note the common thread: two of the three most senior appointments are finance people. In a business whose defining risk for the past five years has been the balance sheet rather than the pigs, that is a legible choice. It is also a departure from the founder's own profile — Muyuan has been run since 1992 by an animal scientist, and is now run by accountants, with the animal scientist relocated to the research institute. Whether that improves capital discipline or dilutes the technical obsession that produced the cost advantage is the open question of this transition.

Read one way, this is textbook institutionalisation: a founder stepping back at 61, an internal veteran of 28 years taking the chair, a finance-trained operator running the company day to day.

Read another way, it is a family transition with extra steps — the chairman is a relative by marriage, the founder retains a lifetime honorary title and control of the research institute, and the son joins the board at 31. Both readings are defensible. What is not in dispute is that control has not moved: Qin Yinglin holds 36.14% directly, Muyuan Industrial Group — owned 100% by Qin and Qian Ying — holds 14.70%, and Qian Ying holds a further 1.12%, for combined control above 50% even after the Hong Kong dilution.⁶

The Hong Kong listing. On February 6, 2026, Muyuan listed H-shares on the Hong Kong Stock Exchange at HK$39.00, offering 273.95 million shares for net proceeds of roughly HK$10.47 billion, rising to as much as HK$12.04 billion if the over-allotment option were fully exercised. Sponsored by Morgan Stanley, CITIC Securities and Goldman Sachs, it was the first A+H dual listing by a Chinese hog producer, and the shares closed their first day at HK$40.52, about 3.9% above the offer price.³ The stated use of proceeds: 60% to global expansion, supply chain and strategic M&A; 30% to breeding and smart-farming R&D; 10% to working capital.³

Two features of the deal are worth flagging. The first is who bought. Cornerstone participation reportedly included Charoen Pokphand Foods — the Thai agribusiness group that is itself one of Asia's largest integrated pork producers — alongside Fidelity funds.³ A strategic competitor taking a cornerstone position in a rival's listing is unusual and suggests the industrial logic of Muyuan's technology export ambitions is taken seriously by people who know the business. The second is the timing. Muyuan listed into a domestic downturn, at a moment when its earnings were about to turn negative, which is not when a company raises equity if it has a choice. Read charitably, management took the window when Hong Kong reopened to Chinese issuers. Read sceptically, it strengthened the balance sheet immediately before a period it already expected to be difficult — which, given what the first half of 2026 delivered, was prudent either way.

The history behind that listing deserves airtime, because it is a direct test of management's capital-markets narrative. Muyuan first pursued a Swiss GDR issue, which the CSRC accepted in January 2023 and the Swiss exchange approved in March. In October 2023 the company terminated it. Board secretary 秦军 Qin Jun explained the decision as reflecting an improved 2023 funding environment, a share price below what management considered fair value, and regulatory uncertainty around overseas issuance.¹⁹ Bloomberg reported the company weighing a Hong Kong listing the following month.³⁰ So the sequence is: abandon one overseas listing on valuation grounds in late 2023, then execute a different one in early 2026 at what was, by then, a considerably lower share price in local terms. Investors are entitled to read this as pragmatism about windows, or as a narrative that bent to circumstance. The more useful observation is what it reveals about intent: Muyuan wanted foreign capital badly enough to try twice.

Deleveraging, tested. Management's stated priority since 2024 has been balance-sheet repair, and for a while the numbers cooperated handsomely. Operating cash flow reached RMB 37.5 billion in 2024 and RMB 30.1 billion in 2025; the company paid RMB 8.09 billion of dividends across two distributions in 2025 and repurchased roughly RMB 2 billion of stock, while cutting total liabilities by RMB 17.1 billion.¹ Interest cover on an EBITDA basis stood at 7.18 times for 2025, and China Chengxin reaffirmed an AA+ issuer rating with a stable outlook on May 19, 2025.¹ By the end of the first quarter of 2026, boosted by H-share proceeds, the debt-to-assets ratio had fallen to 50.73% — the lowest since mid-2021 — and Gao Tong told the quarterly call that with leverage already low, no further debt reduction was planned for the year absent a price recovery.²⁷

Then the cycle bit. By June 30, 2026, the ratio had climbed back to 54.18%, effectively erasing the improvement, and EBITDA interest cover had collapsed from 13.81 times in the first half of 2025 to 3.42 times.⁶ The board declared no interim dividend.⁶ This is the juxtaposition that matters: management's deleveraging claim is real and was executed, but it is contingent on hog prices, not structural. Six months of RMB 10 pork undid a year of repair. The outstanding convertible bond, 牧原转债, had RMB 9.54 billion outstanding at mid-2026 and matures on August 15, 2027, with a final-year coupon step-up to 2.00%.⁶ That is the next hard date on the calendar.

Downstream, overseas and solar. Three growth vectors, at very different stages of proof.

Slaughtering is the most advanced and the most genuinely encouraging. Volumes rose 128.9% in 2025 to 28.66 million head, capacity utilisation hit 98.8%, the business turned its first annual profit after years of losses, and it now operates more than 70 sales branches across 20 provinces.¹ It stayed profitable through both quarters of the 2026 downturn.⁸ Qin Muyuan has framed the next step as shifting the mix away from whole carcasses — still around 70% of sales — toward portioned, small-pack products aimed at China's instant-retail channels.²⁵

The strategic logic is sound: capture the processing margin, gather demand signal, reduce dependence on hog traders. The caution is that at a 2.67% gross margin this remains a razor-thin business in an industry with excess capacity, and its 2025 profit was earned in a year when cheap hogs made processors' economics unusually favourable.

Overseas is early. Muyuan established a Vietnamese subsidiary and signed a joint venture with Vietnam's BAF Agriculture on September 28, 2025, for a multi-storey farming and feed complex in Tây Ninh province: 64,000 sows, 1.6 million market pigs a year, a 600,000-tonne feed mill, total investment of about VND 12 trillion ($454 million).¹⁴ Muyuan has separately explored Philippine and Thai markets, and Reuters reported in March 2024 that the company was planning Vietnamese hog farms alongside a grain-sourcing operation in Brazil.³¹ The first self-built Vietnamese facility was due to begin operating around the turn of April and May 2026.²⁷

This is real activity, but it is a rounding error against a 78-million-head domestic base, and it commits 60% of the H-share proceeds to a thesis — that Muyuan's technology and cost method travel across borders, regulatory systems and labour markets — for which there is as yet no operating evidence. The Brazilian grain initiative in particular should be treated as an intention, not a business.

Incentive alignment. Muyuan has pushed equity ownership deep into the organisation rather than confining it to executives. During 2025 the company ran three parallel schemes — an operators' shareholding plan, a "strivers'" plan and a core-staff plan — covering close to 5,000 senior managers and key employees through employee shareholding platforms.¹ Two of those vehicles appear directly in the top-ten shareholder register, holding 0.98% and 0.41% of the company at mid-2026.⁶ The design intent is legible: in a business where the difference between profit and loss is half a yuan per kilogram, the people who determine that number are farm managers, not headquarters. Whether it works is harder to verify from outside, though the steady, multi-year march of the cost curve is at least consistent with it. The caveat that matters for outside shareholders is that broad internal ownership does not substitute for independent oversight — it aligns employees with the controlling family as much as with minority investors.

Solar is smaller still. Muyuan has targeted distributed photovoltaic capacity of 50 MW by 2025 rising above 10 GW between 2025 and 2030, and reported that green power reached 4.4% of consumption by the end of 2025, avoiding 176,000 tonnes of CO₂-equivalent emissions.²³ Putting panels on the enormous roof area of pig buildings is a sensible use of an otherwise idle asset. It is not, on any realistic assumption, a material driver of the cost curve.

Reading management. The pattern across four years of calls and filings is fairly consistent: specific and quantitative on cost, sow productivity and capital expenditure; considerably vaguer on overseas returns and on the ultimate economics of slaughtering. Gao Tong's language on the first-quarter 2026 call was notably unvarnished — the company had "prepared for an extended industry downturn," expected no inflection in the first half, and acknowledged that fourth-quarter pricing had created immense psychological pressure across the industry.²⁷ Guidance for 2026 hog sales of 75–81 million head against 77.98 million delivered in 2025 is effectively flat,² which is itself a signal: after a decade of compounding volume, management is explicitly choosing not to grow through the trough. Whether that discipline survives the next price spike is the single best future test of this leadership team, given that the last one produced the 2020–2022 building boom.

↑ Back to Top

IX. Framework Analysis: Helmer's 7 Powers & Porter's 5 Forces

Frameworks are only useful if they discriminate, so let's apply them with some scepticism about which powers Muyuan actually has and which it merely resembles.

Scale Economies. This one is straightforward and well evidenced. Central feed formulation, a nucleus genetics programme, equipment engineering, logistics networks and management software all carry substantial fixed costs that Muyuan spreads across roughly 78 million animals — roughly twice the volume of its nearest competitor. Every yuan spent improving a feed formula is amortised across a base no other single company can match. The RMB 1.65 billion R&D budget is only 1.14% of revenue, but per head it funds a level of technical work a five-million-head producer cannot approach.²³ Verdict: present and durable, though it should be noted the marginal returns are visibly diminishing — R&D spending fell in 2025 while cost improvements continued, suggesting the gains now come from operational diffusion rather than fresh invention.

Process Power. This is the most interesting and most contestable claim. Process power in Helmer's framework means an advantage embedded in organisational routines that competitors cannot copy quickly even when they can observe it. Muyuan's candidate is thirty years of accumulated barn design, quarantine protocol, nutritional formulation and stockmanship, propagated through a directly employed workforce of over 127,000 people.²³

The supporting evidence is the persistence of the cost gap: peers have had years to observe Muyuan's methods, several have hired away its managers, and the RMB 2-plus per kilogram gap has not closed. The counter-evidence is that the gap has narrowed at the top end — New Hope's December 2025 cost of RMB 12.2 is not far behind²⁸ — and that much of Muyuan's remaining advantage may be attributable to scale and asset newness rather than irreplicable know-how. Verdict: present, but weaker than the promotional version; the honest formulation is that Muyuan is durably ahead of the industry average, not permanently ahead of the best-run peers.

Counter-Positioning. Historically the strongest of the three. When Muyuan committed to owning every asset, incumbents were locked into contract-farming networks whose entire investor pitch was capital-light returns. Switching would have required them to admit the model was wrong and to raise enormous capital to rebuild what they had deliberately avoided owning. That is a textbook counter-position — and ASF converted it from theory into a decisive advantage. But counter-positioning is a transitional power, not a permanent one. Wens has been building company-owned farms for years; New Hope operates substantial owned capacity. The incumbents have largely adapted. Verdict: historically decisive, now largely spent.

Notably absent are the other four powers. Muyuan has no branding power to speak of — pork is pork, and its consumer brand is embryonic. It has no switching costs; a supermarket chain can change hog suppliers overnight. It has no network economies. It holds no cornered resource, unless one counts the genetics programme, which is valuable but replicable. This is the profile of a low-cost commodity producer, not a franchise business, and investors should price it as such.

Porter's Five Forces, briefly.

Buyer power runs medium and is rising in an oversupplied market. Muyuan's own slaughter integration is the direct response — an attempt to shorten the distance to the consumer rather than sell into a spot market dominated by processors and traders.

Supplier power is the highest of the five, and it is genuinely structural. Corn, wheat and soybean meal represent roughly 55–65% of the cost of raising a pig,¹ and their prices are set by global weather, Brazilian and American harvests, and trade policy. Muyuan's low-soybean formulation is the most credible mitigation any Chinese producer has, and its interest in Brazilian grain sourcing is an attempt to move upstream — but no hog producer controls its principal input.

Threat of new entrants is genuinely low, and getting lower. Building meaningful scale now requires billions of yuan, environmental permits under tightening enforcement, land-use approvals in a country protecting arable land, and biosecurity engineering competence. The bigger risk is not new entrants but existing capacity refusing to exit.

Substitutes are a slow-burn medium. Pork remained 58.96% of China's major meat output in 2025,¹ but poultry and beef consumption have been rising for years, and Chinese per-capita pork consumption has plateaued. This is not a threat to next year's earnings; it is a constraint on the terminal size of the market.

Rivalry is the defining force and it is intense. When a dozen well-capitalised producers all have low marginal costs and enormous sunk fixed assets, nobody exits voluntarily, and prices can sit below full cost for years. The current downturn — running past fifty months by industry reckoning — is the proof.

What would change this assessment? Two things, neither currently in evidence. If Muyuan's branded, portioned meat business scaled to the point where consumers asked for it by name, the company would acquire genuine brand power and pricing latitude — but that business is early, thin-margined and competing against entrenched processors. Alternatively, if the overseas technology-export model worked — if Muyuan could earn fees, royalties or joint-venture returns for transplanting its production system rather than owning the pigs itself — the economics would shift toward something asset-light and genuinely differentiated. The Vietnamese venture is the first real test of that idea. It is worth watching precisely because it is the only path visible today from commodity producer to something structurally better.

The framework verdict is uncomfortable for the simplest bull narrative. Muyuan has real, evidenced advantages in cost and process. It does not have the kind of power that lets a company set prices, and no amount of operational excellence changes the fact that its output is fungible.

↑ Back to Top

X. Bull vs. Bear Case & Key KPIs

The bull case, stated at its strongest.

Start with what is proven rather than promised. Muyuan produces pork more cheaply than anyone else at scale, and the gap has been maintained through both the ASF boom and two separate downturns. That has already converted into share: from roughly 6% of national output in 2021 to 10.8% in 2025, gained precisely while a competitor went through bankruptcy restructuring and another posted losses.² If China's scaled-farming share continues climbing from 73% toward the levels seen in the United States and Western Europe, and if the low-cost operator keeps taking the share the exiting capacity gives up, a path toward 15–20% national share over a decade is arithmetically reasonable.

Second, the fixed-asset base is now largely built. Capital expenditure has fallen to maintenance-plus levels, with only RMB 6–7 billion of the sub-RMB 10 billion 2026 budget representing routine upkeep.²⁵ If that holds through a price recovery, the cash generation of this asset base in a normal year is very large — RMB 30 billion of operating cash flow in 2025, a year with an average hog price at a seven-year low.¹

Third, the downstream business is finally working. Slaughtering reached near-full utilisation and profitability, and remained profitable through the 2026 trough.¹⁸ That reduces reliance on the spot hog market and creates a demand signal the farming business can breed toward.

The bear case, stated at its strongest.

The most powerful bear argument is not a hypothetical. It is the first half of 2026. In a period when Muyuan achieved its lowest-ever production cost, it lost RMB 6.08 billion and burned RMB 2.22 billion of operating cash.⁶ The bull thesis that structural cost leadership "guarantees positive operating cash flow even when peers suffer losses" was tested at RMB 10 pork and failed. It should be retired and replaced with the narrower, defensible version: Muyuan's cost position means it loses far less than the industry and can outlast almost anyone, which is a real advantage but a different one.

Second, the supply overhang looks stubborn. Efficiency gains are partially offsetting the sow-herd reductions the ministry has mandated — Muyuan cut its own breeding herd by roughly 14% while raising PSY enough to recover close to 40% of the lost output.²⁶ If every scaled producer does the same, national capacity reduction translates into far less price relief than the headline sow numbers suggest, and prices can grind near the cost floor for years.

Third, concentration risk cuts both ways. A pathogen that defeats filtered, high-density housing would hit Muyuan disproportionately. There is still no ASF vaccine, and the company's own annual report lists disease as its first enumerated risk factor.²³

Fourth, the balance sheet. Interest cover fell to 3.42 times in the first half of 2026 from 13.81 a year earlier, and the debt ratio round-tripped back above 54% within six months despite an equity raise.⁶ A RMB 9.5 billion convertible matures in August 2027.⁶ Muyuan's funding costs are low and its bank relationships are strong today, but its structure — long assets, short money — is designed for benign credit conditions.

Fifth, governance. Founder-family control above 50%, a chairman related to the founder by marriage, a son on the board at 31, a regulatory interview on the founder's record, continuing related-party construction running against its approved cap, and a fifth of the balance sheet in biological assets flagged as a key audit matter.²⁴²³ None of this is disqualifying. All of it means outside shareholders are relying on the controlling family's judgement and integrity to an unusual degree, with limited independent verification available.

Sixth, and least discussed, is the terminal-demand question. China's population is shrinking and ageing, and pork consumption per head has stopped growing. The industry's own regulator has been cutting the national sow target — from 41 million to 39 million to 37.5 million head over five years¹²⁶ — which is, in effect, an official statement that the market is not expected to expand. A consolidation thesis in a flat or shrinking market can still work, because share gains do the heavy lifting. But it means every yuan of Muyuan's growth has to be taken from a competitor rather than found in the market, and it caps how much capacity the whole industry can profitably support.

What an activist would demand. Put a sceptical long-short investor in front of this company and the asks write themselves. Disclose the unit construction cost of a standard barn, built in-house versus tendered externally, so the related-party pricing claim can be verified rather than asserted. Publish the return on the capital deployed between 2019 and 2022 as a distinct cohort, so shareholders can judge the boom-era building programme on its own terms. Set a hard, declining cap on related-party construction rather than one the company transacts to within a rounding error. Add an independent director with a mandate over related-party review, given the family relationships now spanning the chair, the founder and the board. And commit to a leverage ceiling that binds through a price recovery, not just through a trough — because the record shows this management team deleverages when prices are good and builds when prices are better.

None of these would be unreasonable. None appears to be planned. In a company with founder-family control above 50%, minority shareholders have limited means to force any of them, which is itself part of the investment calculus.

The synthesis. The historical record does not reject Muyuan's core claim — it narrows it. Cost leadership is real, durable so far, and has demonstrably converted into market share through a full cycle. What the record rejects is the stronger corollary that cost leadership makes the business non-cyclical. It does not; it makes the trough survivable rather than profitable. And what the record leaves genuinely unproven is the capital-allocation claim: whether RMB 114 billion of net fixed assets, much of it built at the top of the ASF cycle by a family-owned contractor, will earn an acceptable return across the assets' full lives. That question will not be answered by one good year. It requires a full cycle of cash returns measured against the cost of the concrete.

Three KPIs to watch. Not more than three, and none of them is earnings per share.

First, all-in production cost per kilogram versus the national spot hog price. This is the single number that determines whether Muyuan makes money, and both halves matter. A falling cost with a falling price is not progress. The specific thing to watch is whether the gap to the national average holds near RMB 2–2.5 or compresses as peers modernise.

Second, quarterly hog sales volume together with sow productivity. Volume tells you whether management is honouring its stated discipline of flat output through the trough, or quietly building again. PSY tells you whether the efficiency engine is still improving. Together they reveal whether Muyuan is growing by getting better or by getting bigger — the distinction that separates the 2024–2026 management posture from the 2020–2022 one.

Third, operating cash flow against net debt. The first half of 2026 showed how quickly this can invert. Watch whether operating cash flow recovers to comfortably cover interest, maintenance capital expenditure and the 2027 convertible maturity without new borrowing. This is the metric that will tell you whether the deleveraging story is structural or merely a function of a good price year.

Two things are deliberately left off that list. Quarterly earnings per share, because in this business it is mostly a restatement of the hog price and says little about the company itself. And headline market share, because it lags reality by a year or more and can be flattered simply by competitors exiting rather than by anything Muyuan did.

↑ Back to Top

XI. Outro & Lessons

There is a satisfying symmetry to the Muyuan story that is worth examining critically. Two animal scientists took 22 pigs and spent three decades building the largest livestock operation on Earth; a virus arrived and vindicated an architectural choice that critics had long dismissed; and the founder retired as one of China's richest individuals, handing executive management to a new leadership team. It is a compelling narrative, and most of it holds up.

The investor lessons are less tidy. The first concerns counter-positioning in commodity markets: an asset-heavy operational model is not automatically flawed, but it creates value only when it secures genuine process control rather than simply adding overhead. Muyuan's fifteen years of apparent underperformance were the cost of an option that eventually delivered an extraordinary payoff — yet the same capital-intensive structure that enabled that gain makes cyclical downturns exceptionally punishing.

The second lesson is that engineering can create a competitive moat in unexpected places. Biosecurity was treated as a routine compliance expense until African swine fever turned it into an operational filter separating survival from insolvency. Yet moats built on engineering erode as competitors adopt similar designs, and Muyuan's cost lead over its best-run peers is considerably narrower than its advantage over the industry average.

The third is the oldest rule in commodity investing, which Muyuan's balance sheet repeatedly illustrates: leverage added at the peak of a cycle must be serviced through the trough, and market troughs routinely outlast financial models. Muyuan executed its largest capacity expansion during the highest pork prices in Chinese history, then spent the following five years attempting to reduce its debt burden — only to see those leverage gains partially reverse within six months when prices dropped again.

What comes next remains an open question. A new management team, unproven across a complete cycle, inherits a built-out production footprint, a cost structure unmatched by peers, a Hong Kong listing intended to fund overseas expansion without an operating track record, and a domestic market that Chinese regulators are actively seeking to consolidate and contract. The core thesis reduces to a single premise: that being the lowest-cost producer of a politically essential commodity will ultimately deliver substantial value — provided the balance sheet remains intact long enough to harvest it.

Muyuan Foods Co., Ltd.

Table of Contents

Muyuan Foods: The Pork Empire of Nanyang

I. Introduction & Episode Roadmap

II. Founding Context & The 22-Pig Genesis (1992–2000s)

III. The Architectural Bet: Direct Self-Raising vs. The Contract Model (2000s–2014)

IV. The African Swine Fever Catalyst & The "Pig Skyscraper" Era (2018–2020)

V. The Pig Cycle Crash & The Skeptical Investor Stress Test (2021–2023)

VI. Unit Economics, Cost Leadership, & Segment Mechanics

VII. Competitive Landscape & Industry Structure

VIII. Strategy, Capital Allocation, & Management Transition

IX. Framework Analysis: Helmer's 7 Powers & Porter's 5 Forces

X. Bull vs. Bear Case & Key KPIs

XI. Outro & Lessons

References